SEC Form 4 · accession 0001106578-26-000087
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Jun 26, 2026
Accepted (ET)
Jun 29, 2026 · 4:33 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2026 | M | 9,500 | $135.42 | A | 50,013 | D | |
| Common StockF2 | Jun 26, 2026 | S | 640 | $538.3425 | D | 49,373 | D | |
| Common StockF3 | Jun 26, 2026 | S | 1,018 | $539.8906 | D | 48,355 | D | |
| Common StockF4 | Jun 26, 2026 | S | 2,128 | $541.2376 | D | 46,227 | D | |
| Common StockF5 | Jun 26, 2026 | S | 983 | $542.1444 | D | 45,244 | D | |
| Common StockF6 | Jun 26, 2026 | S | 1,012 | $543.3196 | D | 44,232 | D | |
| Common StockF7 | Jun 26, 2026 | S | 439 | $544.1783 | D | 43,793 | D | |
| Common StockF8 | Jun 26, 2026 | S | 560 | $545.5158 | D | 43,233 | D | |
| Common StockF9 | Jun 26, 2026 | S | 156 | $547.0047 | D | 43,077 | D | |
| Common StockF10 | Jun 26, 2026 | S | 452 | $548.1282 | D | 42,625 | D | |
| Common StockF11 | Jun 26, 2026 | S | 872 | $548.8997 | D | 41,753 | D | |
| Common StockF12 | Jun 26, 2026 | S | 520 | $549.6867 | D | 41,233 | D | |
| Common StockF13 | Jun 26, 2026 | S | 400 | $550.7926 | D | 40,833 | D | |
| Common StockF14 | Jun 26, 2026 | S | 280 | $552.3624 | D | 40,553 | D | |
| Common Stock | Jun 26, 2026 | S | 40 | $553.49 | D | 40,513 | D | |
| Common Stock | holding | — | — | — | 166 | I | by Spouse | |
| Common StockF15 | holding | — | — | — | 324,443 | I | by Trust | |
| Common StockF16 | holding | — | — | — | 249,108 | I | by Trust | |
| Common StockF17 | holding | — | — | — | 45,596 | I | by Trust | |
| Common StockF18 | holding | — | — | — | 8,902 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $135.42 | Jun 26, 2026 | M | 9,500 | D | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 9,500 | 106,218 | D |
| Stock OptionF19 | $135.42 | holding | — | — | — | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 349,192 | 349,192 | I |
Explanation of responses
- F1This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10This transaction was executed in multiple trades at prices ranging from $547.39 to $548.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $548.41 to $549.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12This transaction was executed in multiple trades at prices ranging from $549.43 to $550.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13This transaction was executed in multiple trades at prices ranging from $550.56 to $551.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14This transaction was executed in multiple trades at prices ranging from $552.05 to $552.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F16Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F18Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F19Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2This transaction was executed in multiple trades at prices ranging from $538.18 to $538.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $539.66 to $540.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $540.67 to $541.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $541.67 to $542.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $542.74 to $543.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $543.825 to $544.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $545.23 to $546.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $546.39 to $547.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.